No Data
No Data
No Data
No Data
No Data
Express News | Jincheng Pharmaceutical: The subsidiary received a registration certificate for injectable cefminol
BreakingsApr 29 20:59
Express News | Jincheng Pharmaceutical: The subsidiary received a notice of approval for the marketing application of the chemical raw material oseltamivir phosphate
BreakingsApr 25 17:01
Jincheng Pharmaceutical (300233.SZ) plans to distribute a cash dividend of 2 yuan for every 10 shares
Jincheng Pharmaceutical (300233.SZ) issued an implementation notice for the 2023 equity distribution. The company gave all shareholders every...
Zhitong FinanceApr 24 21:24
Jincheng Pharmaceutical (300233.SZ): Net profit of 82.97 million yuan in the first quarter increased 65.43% year-on-year
On April 24, Gelonghui Pharmaceutical (300233.SZ) released its first quarter report. Operating revenue was 930 million yuan, up 12.32% year on year, net profit of 82.97 million yuan, up 65.43% year on year, after deducting non-net profit of 80.31 million yuan, up 87.19% year on year, with basic earnings per share of 0.22 yuan.
Gelonghui FinanceApr 24 16:59
Jincheng Pharmaceutical (300233.SZ): As of April 10, 2024, the number of shareholders of the company was 25,519
Gelonghui April 16 | Jincheng Pharmaceutical (300233.SZ) said on the investor interactive platform that as of April 10, 2024, the number of shareholders of the company was 25,519.
Gelonghui FinanceApr 16 16:22
Jincheng Pharmaceutical (300233.SZ): Taking “Women's Health Technology” as one of the key development areas in the future
Gelonghui, April 9, 丨 Jincheng Pharmaceutical (300233.SZ) held a performance briefing on April 9, 2024 to discuss “If the company's participation in Dongfang Lue's VGX-3100 is approved for listing in the future, will the company actively participate in it?” The company replied that the company regards “women's health technology” as one of the key development areas in the future, and that if Dongfanglue VGX-3100 is approved for listing, the company will actively engage in negotiations with it.
Gelonghui FinanceApr 9 17:45
No Data
No Data